Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow

Shruti Sharma, Sanjiv Kumar, Neetu Sud, Dean A. Wiseman, Jing Tian, Imran Rehmani, Sanjeev Datar, Peter Oishi, Sohrab Fratz, Richard C Venema, Jeffrey R. Fineman, Stephen Matthew Black

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Previous studies demonstrate impaired nitric oxide (NO) signaling in children and animal models with congenital heart defects and increased pulmonary blood flow. However, the molecular mechanisms underlying these alterations remain incompletely understood. The purpose of this study was to determine if early changes in arginine metabolic pathways could play a role in the reduced NO signaling demonstrated in our lamb model of congenital heart disease with increased pulmonary blood flow (Shunt lambs). The activities of the arginine recycling enzymes, argininosuccinate synthetase (ASS) and argininosuccinate lyase (ASL) were both decreased in lung tissues of Shunt lambs while arginase activity was increased. Associated with these alterations, lung L-arginine levels were decreased. These changes correlated with an increase in NO synthase-derived reactive oxygen species (ROS) generation. This study provides further insights into the molecular mechanisms leading to decreased NO signaling in Shunt lambs and suggests that altered arginine metabolism may play a role in the development of the endothelial dysfunction associated with pulmonary hypertension secondary to increased pulmonary blood flow.

Original languageEnglish (US)
Pages (from-to)359-364
Number of pages6
JournalVascular Pharmacology
Volume51
Issue number5-6
DOIs
StatePublished - Nov 1 2009

Fingerprint

Pulmonary Hypertension
Arginine
Lung
Nitric Oxide
Argininosuccinate Lyase
Argininosuccinate Synthase
Arginase
Congenital Heart Defects
Metabolic Networks and Pathways
Nitric Oxide Synthase
Heart Diseases
Reactive Oxygen Species
Animal Models
Enzymes

Keywords

  • Arginase
  • Argininosuccinate lyase
  • Argininosuccinate synthetase
  • Cationic amino acid transporter-1
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Physiology
  • Molecular Medicine
  • Pharmacology

Cite this

Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow. / Sharma, Shruti; Kumar, Sanjiv; Sud, Neetu; Wiseman, Dean A.; Tian, Jing; Rehmani, Imran; Datar, Sanjeev; Oishi, Peter; Fratz, Sohrab; Venema, Richard C; Fineman, Jeffrey R.; Black, Stephen Matthew.

In: Vascular Pharmacology, Vol. 51, No. 5-6, 01.11.2009, p. 359-364.

Research output: Contribution to journalArticle

Sharma, S, Kumar, S, Sud, N, Wiseman, DA, Tian, J, Rehmani, I, Datar, S, Oishi, P, Fratz, S, Venema, RC, Fineman, JR & Black, SM 2009, 'Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow', Vascular Pharmacology, vol. 51, no. 5-6, pp. 359-364. https://doi.org/10.1016/j.vph.2009.09.005
Sharma, Shruti ; Kumar, Sanjiv ; Sud, Neetu ; Wiseman, Dean A. ; Tian, Jing ; Rehmani, Imran ; Datar, Sanjeev ; Oishi, Peter ; Fratz, Sohrab ; Venema, Richard C ; Fineman, Jeffrey R. ; Black, Stephen Matthew. / Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow. In: Vascular Pharmacology. 2009 ; Vol. 51, No. 5-6. pp. 359-364.
@article{c3fa997dcd4047269063baa4cf88ddc6,
title = "Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow",
abstract = "Previous studies demonstrate impaired nitric oxide (NO) signaling in children and animal models with congenital heart defects and increased pulmonary blood flow. However, the molecular mechanisms underlying these alterations remain incompletely understood. The purpose of this study was to determine if early changes in arginine metabolic pathways could play a role in the reduced NO signaling demonstrated in our lamb model of congenital heart disease with increased pulmonary blood flow (Shunt lambs). The activities of the arginine recycling enzymes, argininosuccinate synthetase (ASS) and argininosuccinate lyase (ASL) were both decreased in lung tissues of Shunt lambs while arginase activity was increased. Associated with these alterations, lung L-arginine levels were decreased. These changes correlated with an increase in NO synthase-derived reactive oxygen species (ROS) generation. This study provides further insights into the molecular mechanisms leading to decreased NO signaling in Shunt lambs and suggests that altered arginine metabolism may play a role in the development of the endothelial dysfunction associated with pulmonary hypertension secondary to increased pulmonary blood flow.",
keywords = "Arginase, Argininosuccinate lyase, Argininosuccinate synthetase, Cationic amino acid transporter-1, Pulmonary hypertension",
author = "Shruti Sharma and Sanjiv Kumar and Neetu Sud and Wiseman, {Dean A.} and Jing Tian and Imran Rehmani and Sanjeev Datar and Peter Oishi and Sohrab Fratz and Venema, {Richard C} and Fineman, {Jeffrey R.} and Black, {Stephen Matthew}",
year = "2009",
month = "11",
day = "1",
doi = "10.1016/j.vph.2009.09.005",
language = "English (US)",
volume = "51",
pages = "359--364",
journal = "Vascular Pharmacology",
issn = "1537-1891",
publisher = "Elsevier Inc.",
number = "5-6",

}

TY - JOUR

T1 - Alterations in lung arginine metabolism in lambs with pulmonary hypertension associated with increased pulmonary blood flow

AU - Sharma, Shruti

AU - Kumar, Sanjiv

AU - Sud, Neetu

AU - Wiseman, Dean A.

AU - Tian, Jing

AU - Rehmani, Imran

AU - Datar, Sanjeev

AU - Oishi, Peter

AU - Fratz, Sohrab

AU - Venema, Richard C

AU - Fineman, Jeffrey R.

AU - Black, Stephen Matthew

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Previous studies demonstrate impaired nitric oxide (NO) signaling in children and animal models with congenital heart defects and increased pulmonary blood flow. However, the molecular mechanisms underlying these alterations remain incompletely understood. The purpose of this study was to determine if early changes in arginine metabolic pathways could play a role in the reduced NO signaling demonstrated in our lamb model of congenital heart disease with increased pulmonary blood flow (Shunt lambs). The activities of the arginine recycling enzymes, argininosuccinate synthetase (ASS) and argininosuccinate lyase (ASL) were both decreased in lung tissues of Shunt lambs while arginase activity was increased. Associated with these alterations, lung L-arginine levels were decreased. These changes correlated with an increase in NO synthase-derived reactive oxygen species (ROS) generation. This study provides further insights into the molecular mechanisms leading to decreased NO signaling in Shunt lambs and suggests that altered arginine metabolism may play a role in the development of the endothelial dysfunction associated with pulmonary hypertension secondary to increased pulmonary blood flow.

AB - Previous studies demonstrate impaired nitric oxide (NO) signaling in children and animal models with congenital heart defects and increased pulmonary blood flow. However, the molecular mechanisms underlying these alterations remain incompletely understood. The purpose of this study was to determine if early changes in arginine metabolic pathways could play a role in the reduced NO signaling demonstrated in our lamb model of congenital heart disease with increased pulmonary blood flow (Shunt lambs). The activities of the arginine recycling enzymes, argininosuccinate synthetase (ASS) and argininosuccinate lyase (ASL) were both decreased in lung tissues of Shunt lambs while arginase activity was increased. Associated with these alterations, lung L-arginine levels were decreased. These changes correlated with an increase in NO synthase-derived reactive oxygen species (ROS) generation. This study provides further insights into the molecular mechanisms leading to decreased NO signaling in Shunt lambs and suggests that altered arginine metabolism may play a role in the development of the endothelial dysfunction associated with pulmonary hypertension secondary to increased pulmonary blood flow.

KW - Arginase

KW - Argininosuccinate lyase

KW - Argininosuccinate synthetase

KW - Cationic amino acid transporter-1

KW - Pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=70449525329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449525329&partnerID=8YFLogxK

U2 - 10.1016/j.vph.2009.09.005

DO - 10.1016/j.vph.2009.09.005

M3 - Article

VL - 51

SP - 359

EP - 364

JO - Vascular Pharmacology

JF - Vascular Pharmacology

SN - 1537-1891

IS - 5-6

ER -